ÂÜÀòÂÒÂ×

Eli Kammerman has extensive experience in the medical devices and financial sectors, currently serving as Vice President of Business Development and Investor Relations at Masimo Corp. since June 2009. Prior to this role, Eli held positions as a Medical Devices Analyst at Cowen & Co. and Cathay Financial, as well as Vice President of Early Commercial Development at Novartis Pharmaceuticals. Early career experience includes roles as a Medical Devices Analyst at Raymond James Financial, Inc., Salomon Brothers, and a Biotech Associate Analyst at Merrill Lynch. Eli holds a Bachelor of Arts degree in Biology from Boston University and is enrolled in a Master's program in Technology Management at the University of Maryland Global Campus.